Reimagine Care and Dan Nardi scale CAR-T programs with remote cancer care, AI triage and nurses, as the Cureety partnership tackles staffing and access.
|Slideshows|October 9, 2018
- Managed Healthcare Executive November 2018 Issue
- Volume 28
- Issue 11
Eight Top Oncology Drug Approvals
Author(s)Erin Johanek, PharmD, RPh
New cancer drugs continue to offer patients hope. Here are eight of them.
Advertisement
Articles in this issue
almost 8 years ago
Looser Restrictions on HRAs on the Horizonalmost 8 years ago
Nine Ways to Deal with Escalating Drug Costsalmost 8 years ago
Time to Address ‘Financial Toxicity’ of Cancer Treatmentalmost 8 years ago
CAR T-cell Therapy: How Payers are Responding to Huge Price Tagsalmost 8 years ago
Medical Foods Strive for Insurance Coveragealmost 8 years ago
New Chiefs at MCOs: 4 Positions You May Want to Addalmost 8 years ago
Eight Predictions for Cancer Care in 10 Yearsover 8 years ago
Is Precision Medicine Worth the Hype? Oncologists Weigh InAdvertisement
Related to this article
Dan Nardi shares how Reimagine Care uses AI triage and connected devices to scale outpatient cancer support, enabling faster, personalized symptom monitoring.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
8 dermatology developments from 2026 that experts say matter most | 2026 Fall Clinical Derm
2
New acute low back pain guideline steers clinicians away from routine imaging and opioids
3
A conversation about the cycle of ADHD and sleep problems in children, with Alison Pritchard, Ph.D.
4
Home sleep apnea testing faces payment cut under 2027 CMS rule
5